Dr. Venkata S.r. Pulakanti, MD

Dr. Pulakanti practices at Wound Masters in Los Angeles, California.

Dr. Pulakanti's NPI, 1356521843, was assigned on November 13, 2007. Dr. Pulakanti graduated from Andhra Medical College NTR in 1979. Dr. Pulakanti holds California license A51071.

Dr. Pulakanti's primary practice is Wound Masters, at 3415 S Sepulveda Blvd, Los Angeles, CA 90034. The practice phone is (833) 362-7837.

Dr. Pulakanti's primary practice is Wound Masters in Los Angeles, California. Dr. Pulakanti is also affiliated with San Antonio Regional Hospital. The medical group on file is Wound Masters. Dmand AI also links Dr. Pulakanti to 6 more medical groups, 5 hospices, 4 group practices and clinics, 4 home health agencies and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pulakanti practices, 16 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Pulakanti's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Pulakanti's licenses on file in 4 states: California, New Jersey, New York and Arizona.

Dmand AI lists chronic diabetes, chronic hypertension, joint pain, neck pain and spine problems, tobacco use and upper respiratory infection (URI) among the conditions Dr. Pulakanti treats.

CMS data shows 1,505 Medicare services from Dr. Pulakanti across 8 procedure codes in 2024, for 267 Medicare patients. Medicare paid $315,786 for them. Every service was in an office.

CMS counts 267 Medicare patients who saw Dr. Pulakanti in 2024. The largest group is 85 and over, with 92 patients. 72% of them have high blood pressure, and 60% have high cholesterol. 40% are also on Medicaid. Their average risk score is 3.22, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pulakanti's median patient age at 69, with 48% women.

In 2024, Dr. Pulakanti wrote 4,589 Medicare Part D claims for 781 patients. 86% of them were for generic drugs. CMS names the drug for 3,947 of them, across 100 drugs with 11 or more claims each, at $290,108 in total drug cost. In 2023, CMS named 5,269 claims across 116 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 49 out of 100 for Dr. Pulakanti for performance year 2024, reported as part of a group. Dr. Pulakanti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Pulakanti as offering telehealth. CMS counts 200 procedures of removal of tissue by Dr. Pulakanti, more than 91% of the clinicians it reports for that procedure.

CMS Open Payments shows 302 general payments to Dr. Pulakanti from 34 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $935.

Dr. Pulakanti graduated from Andhra Medical College NTR in 1979.

Dr. Pulakanti is in network with 7 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.